Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA OK's Odomzo from Novartis for common skin cancer type
FDA OK's Odomzo from Novartis for common skin cancer type
FDA OK's Odomzo from Novartis for common skin cancer type
Submitted by
admin
on July 25, 2015 - 9:41am
Source:
Yahoo/AP
News Tags:
FDA
Odomzo
Novartis
basal cell carcinoma
skin cancer
Headline:
FDA OK's Odomzo from Novartis for common skin cancer type
Do Not Allow Advertisers to Use My Personal information
